Centessa shareholders approve all proposals at 2024 AGM

Centessa Pharmaceuticals plc

Directors Francesco De Rubertis, Saurabh Saha, and Mary Lynne Hedley re-elected with 67.8M, 76.4M, and 76.6M votes For respectively.
KPMG LLP (UK) re-appointed as statutory auditor, and KPMG LLP (US) ratified as independent auditor, each with 88.9M For votes.
Advisory resolution to approve directors' remuneration report passed with 76.7M For votes.
Authority to allot shares up to £100,740 nominal and disapply pre-emption rights approved with 68.0M and 64.6M For votes respectively.
All resolutions passed; no dividend recommended for FY2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.